SPRB Stock Analysis: Buy, Sell, or Hold?
SPRB - Spruce Biosciences, Inc. Common Stock
$77.00
-0.55 (-0.71%)
▼
5d:
-6.88%
30d:
-11.61%
90d:
-28.21%
HOLD
LOW Confidence
Last Updated: February 2, 2026
Get Alerted When SPRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SPRB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SPRB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SPRB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SPRB is currently trading at $77.00, which is considered slightly low relative to its 30-day fair value range of $75.99 to $84.76.
Technical Outlook: Technically, SPRB is showing sideways momentum. Immediate support is located at $71.46, while resistance sits at $87.40.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $230.50 (+197.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SPRB is showing sideways momentum. Immediate support is located at $71.46, while resistance sits at $87.40.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $230.50 (+197.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$75.99 -
$84.76
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 197.2% below Wall St target ($230.50)
- CAUTION: Recommendation downgraded due to -6.9% 5-day decline
Fair Price Analysis
30-Day Fair Range
$75.99 -
$84.76
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$71.46
Resistance Level
$87.40
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-2.35
Wall Street Target
$230.50
(+197.2%)
Revenue Growth (YoY)
-75.9%
Last updated: February 02, 2026 2:19 PM ET
Data refreshes hourly during market hours. Next update: 3:19 PM
Data refreshes hourly during market hours. Next update: 3:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 56 HOLD |
